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Ultraviolet light is one of the most crucial environmental factors with regard to its capacity to induce skin cancer,
premature aging of the skin, and immunosuppression. Although ultraviolet directly affects the function of
epidermal cells, many of these effects are mediated by induction of cytokines, growth factors, and neuropeptides,
such as a-melanocyte-stimulating hormone. Recently, in addition to its well-known pigmentation inducing activity,
a strong anti-inﬂammatory as well as an immunomodulatory potential of a-melanocyte-stimulating hormone has
been recognized. The aim of this study was to determine, whether ultraviolet irradiation affects the expression of
both a-melanocyte-stimulating hormone and the melanocortin-1 receptor in human epidermis in vivo. The volar
aspects of the forearms were exposed to twice the minimal erythema dose of solar-simulating radiation. Three, 6,
and 24 h after irradiation, the proopiomelanocortin and interleukin-10 mRNA levels in suction blister induced
epidermal sheets were considerably upregulated as detected by semiquantitative reverse transcription–
polymerase chain reaction. Furthermore, a-melanocyte-stimulating hormone and interleukin-10 protein levels in
blister ﬂuids were signiﬁcantly increased 24 h after ultraviolet irradiation, an effect that could be abolished by
application of the broad-spectrum sunscreen Anthe´lios XL prior to ultraviolet (solar-simulating radiation)
exposure. In addition, enhanced melanocortin-1 receptor mRNA and receptor protein expression upon solar-
simulating radiation was ascertained by reverse transcription–polymerase chain reaction and immunohistochem-
istry of the epidermal sheets, respectively. Proopiomelanocortin-derived neuropeptides, such as a-melanocyte-
stimulating hormone may therefore play an important part in modulating ultraviolet-induced inﬂammation.
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Introduction
Proopiomelanocortin (POMC) peptides, originally identified
as pituitary neurohormones, are now established as being
produced by several extra-neural tissues, including skin
(Thody et al, 1983; Schauer et al, 1994; Slominski et al,
1995; Chakraborty et al, 1996; Wintzen and Gilchrest, 1996;
Scholzen et al, 2000; Schiller et al, 2001). Under normal
conditions, however, these peptides are detectable only in
minimal amounts in epidermal cells, whereas pro-inflam-
matory cytokines such as interleukin (IL)-1 and bacterial
endotoxin are well known for their capacity to upregulate
POMC mRNA and POMC-derived peptides expression,
including a-melanocyte-stimulating hormone (a-MSH),
adrenocorticotropin (ACTH), b-lipotropic hormone, and
b-endorphin (reviewed in Slominski et al, 2000; Slominski
and Wortsman, 2000). Furthermore ultraviolet light (UV), one
of the most significant environmental factors due to its
capacity to induce skin cancer, premature skin aging, and
immunosuppression (reviewed in Beissert and Granstein,
1996; Beissert and Schwarz, 1999), turned out to be a
strong inducer of POMC-derived peptide expression (re-
viewed in Scholzen et al, 1999; Luger et al, 2002).
Two prohormone convertases, PC1 and PC2, belonging
to an evolutionary conserved family of serine proteinases of
the subtilisin/kexin-type, have been found to be mainly
involved in POMC processing and expression (Seidah et al,
1999). Whereas PC1 activity results in ACTH and b-lipo-
tropin formation, PC2 catalyzes for the formation of a-MSH,
b-endorphin, and corticotropin-like intermediate lobe pep-
tide (Benjannet et al, 1991; Seidah et al, 1999). PC2 activity1These authors contributed equally to this work.
Abbreviations: MC-R, melanocortin receptor; MED, minimal er-
ythema dose; MSH, melanocyte-stimulating hormone; PC, pro-
hormone convertase; POMC, proopiomelanocortin; SSR, solar-
simulating radiation.
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itself is partly regulated by a chaperone-like binding protein
named 7B2, which facilitates zymogene activation of the
precursor PC2 (Benjannet et al, 1998; Apletalina et al, 2000).
This enzyme machinery has also been detected in various
skin cells types, such as keratinocytes, human melano-
cytes, human dermal microvascular endothelial cells, and
human dermal fibroblasts (Wakamatsu et al, 1997; Peters
et al, 2000; Scholzen et al, 2000; Schiller et al, 2001).
With regard to the skin, a-MSH among the POMC
peptides has attained most attraction, originally being
implicated as a mediator of skin darkening (Lerner and
McGuire, 1961; Abdel-Malek et al, 1995; Thody and
Graham, 1998). In addition, an increasing number of studies
demonstrated that a-MSH exerts potent immunoregulatory
effects. These appear to be relevant for cutaneous immune
responses and inflammation (reviewed in Lipton and
Catania, 1997; Luger et al, 2000; Slominski et al, 2000).
a-MSH suppresses the production of certain immunoregu-
latory and pro-inflammatory cytokines such as IL-1, IL-6,
interferon-g, and tumor necrosis factor (TNF)-a (Catania and
Lipton, 1993; Luger et al, 1999). Expression of the
costimulatory molecules CD86 and CD40 is suppressed
by a-MSH (Bhardwaj et al, 1997). a-MSH induces the
production of the cytokine synthesis inhibitory factor IL-10
in human monocytes (Bhardwaj et al, 1996; Becher et al,
1999). It also downregulates lipopolysaccharide- or TNF-a-
induced expression of the vascular cellular adhesion
molecule 1 and intercellular adhesion molecule-1 (Hedley
et al, 1998; Morandini et al, 1998; Scholzen et al, 2003).
Moreover, a-MSH and its carboxy-terminal tripeptide are
capable of suppressing lipopolysaccharide- or IL-1-
mediated activation of the transcription factor nuclear
factor-kB (Manna and Aggarwal, 1998; Brzoska et al,
1999; Ichiyama et al, 1999; Haddad et al, 2001; Mandrika
et al, 2001). In vivo, these anti-inflammatory activities of
a-MSH were exemplified in mouse models of contact
dermatitis and experimentally induced vasculitis (Grabbe
et al, 1996).
a-MSH and ACTH elicit their biologic actions by binding
to melanocortin receptors (MC-R), a group of G-protein-
coupled receptors with seven transmembrane domains.
Binding of the ligand to the receptor results in an
accumulation of intracellular cyclic adenosine monopho-
sphate (Abdel-Malek et al, 2000; Busca and Ballotti, 2000).
Five melanocortin receptors have been cloned so far (MC-
1R to MC-5R) (reviewed in Cone et al, 1996). The MC-1R is
coded for by a gene locus that is crucially involved in
determining mouse coat color (extension locus), whereas
agouti, another key coat color-determining gene locus,
codes for a protein that operates as a high-affinity
antagonist of both the MC-1R and the MC-4R (Lu et al,
1994; Slominski et al, 2000; Abdel-Malek, 2001). Although
a-MSH binds several MC-R subtypes, MC-1R has the
highest affinity for a-MSH and in addition ACTH, followed by
b-MSH and g-MSH (Chhajlani and Wikberg, 1992; Lu et al,
1994; Cone et al, 1996; Wintzen and Gilchrest, 1996).
Although MC-1R expression was originally found to be
expressed in melanocytes, it is now established that several
skin types cell, such as microvascular dermal endothelial
cells (Hartmeyer et al, 1997), sebocytes (Bo¨hm et al, 2002),
and dermal fibroblasts (Bo¨hm et al, 2004), express functional
MC-1R. Depending on the cell type studied, a-MSH either up-
regulates or downregulates expression of its own receptor
(Cone et al, 1996).
The aim of this study was to increase our current
knowledge on the UV-mediated induction of a-MSH as well
as its potential role in skin inflammation. We provide
evidence that solar-simulated radiation (SSR) in vivo results
in both the increased generation of the POMC peptide
a-MSH and the upregulated expression of MC-1R.
Results
Upregulation of MC-1R mRNA expression by SSR in the
human epidermis The constitutive expression MC-1R in
human epidermal keratinocytes in vitro is well established
(Brzoska et al, 1997). Previously, it also has been demon-
strated that UV irradiation is one of the major stimuli for
MC-1R mRNA expression in melanocytes and keratinocytes
in vitro and in vivo (Chakraborty et al, 1995, 1996, 1999a,b;
Slominski and Pawelek, 1998). To substantiate further the
physiologic relevance of these findings in humans, we
performed an in vivo reverse transcriptase–PCR study using
a SSR. The volar aspects of the forearm of five healthy
volunteers were left unirradiated (control) or were irradiated
with 2  MED using a solar simulator. At indicated time-
points, epidermal sheets were obtained by the suction
blister technique and total RNA was prepared. MC-1R
mRNA expression was determined by semiquantitative
reverse transcriptase–PCR with the amplification of a 416
bp MC-1R fragment. The amplification of an 838 bp b-actin
fragment served as internal control reflecting the relative
amount of mRNA in each sample. As shown in Fig 1a
nonirradiated epidermal keratinocytes in vivo constitutively
express low levels of MC-1R mRNA. Semiquantitative
densitometric evaluation of MC-1R-specific PCR products
revealed that SSR upregulated MC-1R mRNA with a 3- to
4-fold induction compared with unirradiated controls at 3
and 6 h postirradiation, respectively; though, this effect
achieved statistical significance only 6 h postirradiation
(po0.05) (Fig 1a,b left panel).
Regulation of POMC and IL-10 mRNA expression by
SSR in the human epidermis As normal human epidermal
keratinocytes are well recognized to express the MC-1R
and to simultaneously produce POMC in vitro (Schauer et al,
1994; Wintzen and Gilchrest, 1996), it has subsequently
been demonstrated that a variety of stimuli are capable of
augmenting POMC expression in keratinocytes. UV irradia-
tion is one of the major stimuli for POMC mRNA and peptide
expression in epidermal cells (Chakraborty et al, 1996;
Luger et al, 1999). In order to assess further the biologic
significance of the UV-mediated upregulation of POMC
peptides, we determined the impact of solar-simulated
irradiation on POMC mRNA expression as outlined above.
Reverse transcriptase–PCR was performed using the
amplification of a 143 bp POMC fragment that corresponds
to POMC exon 2. Unirradiated control cells already
constitutively express modest levels of POMC mRNA at
all time points (Fig 1a). Irradiation with SSR (2  MED)
increased the amount of POMC mRNA with an almost
3-fold induction compared with unirradiated controls at 3 h
UV REGULATION OF POMC SYSTEM IN HUMAN SKIN 469122 : 2 FEBRUARY 2004
postirradiation with a subsequent decline to 2-fold levels of
POMC expression 6 h after irradiation; however, this result
did not achieved statistical significance (Fig 1a,b middle
panel).
As UV irradiation has been shown to inhibit at least in
part contact hypersensitivity reaction via the release of
POMC peptides and upregulation of suppressor factors
such as IL-10, the effects of SSR on the expression of IL-10
mRNA has been investigated. SSR resulted in a transient
expression profile of IL-10 mRNA that strongly resembled
that of POMC mRNA expression. Maximum IL-10 mRNA
levels were observed 3 h after irradiation with a 3.5-fold
induction compared with unirradiated control (po0.05 (UV
vs control)), followed by a slight decrease 6 h postirradiation
(not statistically significant (control vs UV)) (Fig 1a,b right
panel).
Prevention of POMC and IL-10 mRNA upregulation after
UV irradiation by a broad-spectrum sunscreen In vitro
studies of keratinocytes or dermal endothelial cells demon-
strated that the POMC mRNA expression profile following
UVB irradiation initially peaks 1 to 6 h after irradiation and is
followed by a second incline after 24 to 48 h (Brzoska et al,
1997; Scholzen et al, 2000). This late inductive effect may
be explained by the autocrine effect of UV-induced
inflammatory cytokines such as IL-1, known to be a potent
inducer of in vitro POMC mRNA expression (Schauer et al,
1994; Chakraborty et al, 1996; Wintzen and Gilchrest, 1996;
Scholzen et al, 2000). To substantiate further the relevance
of these in vitro findings, in a second set of experiments, the
volar aspects of the forearm of three volunteers were either
left unirradiated (control) or irradiated with 2  MED using a
solar simulator. The irradiated area was left untreated or
treated with Anthe´lios XL or its vehicle control. Epidermal
sheets were obtained 24 h after SSR. As demonstrated by
reverse transcriptase–PCR POMC and IL-10 mRNA levels
were considerably enhanced as compared with untreated
control samples 24 h after UV exposure (Fig 2, lanes 1 and
2). Densitometric quantification revealed up to 6.2-fold and
6.9-fold increase of POMC and IL-10 mRNA expression by
SSR, respectively. Importantly, the effect of SSR on the
in vivo POMC and IL-10 mRNA expression could be
completely prevented by pretreatment of the irradiated area
with the broad-spectrum sunscreen Anthe´lios XL (0.5-fold
and 0.8-fold over control, respectively), whereas pretreat-
ment with the vehicle control had no substantial effect (8.2-
fold and 5.6-fold over control, respectively) (Fig 2, lanes 3
and 4). Notably, the treatment with sunscreen was able to
prevent visible erythema formation, whereas the vehicle did
not (not shown).
UV irradiation increases the production of a-MSH and
IL-10 in vivo In order to investigate whether UV-induced
expression of POMC mRNA is accompanied by an
increased release of the POMC peptides and the anti-
inflammatory IL-10 in vivo. In preliminary experiments
substantial upregulation of a-MSH were found 24, 48, and
72 h post-UV irradiation (not shown). This is in agreement
with previous in vitro studies, which have shown that
production of a-MSH and other POMC-peptides such as
ACTH and b-lipotropic hormone becomes maximal within
24 to 48 h after UV exposure (Chakraborty et al, 1995, 1996;
Wintzen and Gilchrest, 1996; Scholzen et al, 2000).
Subsequently, suction blister fluids were collected 24 h
after UV irradiation (as a representative data time-point) in
five volunteers. Immunoreactive a-MSH and IL-10 were
determined using specific immunoassays (see Materials
and Methods) in low but considerable amounts (a-MSH:
16.5  9.2 pg per mL and IL-10: 16.1  6.8 pg per mL;
mean  SD) 24 h post-mock irradiation in vivo (Fig 3a,b).
SSR (2  MED) induced a considerable increase of a-MSH
Figure 1
Upregulation of MC-1R, POMC, and IL-10 mRNA after UV
irradiation in vivo. The volar aspects of the forearm of five healthy
volunteers were left unirradiated (control) or were irradiated with
2  MED using a solar simulator. Suction blisters were induced 3 h or 6
h after irradiation, and total RNA from epidermal roofs was subjected to
reverse transcriptase–PCR. (a) Amplification products of MC-1R,
POMC, IL-10, and b-actin were separated on agarose gels, and (b)
evaluated densitometrically to semiquantify mRNA expression. Results
are expressed as b-actin normalized relative mRNA levels (mean  SD)
of five different experiments. po0.05 versus control. The absence of
superscript means the differences were not statistically significant.
Figure2
Broad-spectrum sunscreen prevents upregulation of POMC and
IL-10 mRNA after UV irradiation in vivo. The volar aspects of the
forearm of three volunteers were left unirradiated (control) or were
irradiated with 2  MED using a solar simulator. The irradiated area
was either left untreated or treated with Anthe´lios XL or its common
vehicle control. Suction blisters were induced 24 h after irradiation, and
total mRNA from epidermal roofs was subjected to reverse transcrip-
tase–PCR. Amplification products of POMC, IL-10, and b-actin were
separated on agarose gels. One representative set of data of three
different experiments is shown.
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(45.0  18.4 pg per mL) and IL-10 (49.6  21.9 pg per mL)
in the suction blister fluids as compared with samples of
unirradiated skin after 24 h, whereas treatment with the
broad-spectrum sunscreen Anthe´lios XL prior to irradiation
led to an almost complete reduction of the a-MSH and IL-10
levels (20.1  14.8 pg per mL, 26.3  9.9 pg per mL,
respectively) in comparison with UV light only (po0.05
(control vs UV vs sunscreen)) (Fig 3a,b).
Induction of MC-1R expression in epidermal blister
sheets following SSR in vivo We next performed im-
munohistochemical studies on epidermal sheets 24 h after
irradiation with SSR in three healthy volunteers. In accor-
dance with previously reported findings (Xia et al, 1995;
Bo¨hm et al, 1999) all layers of the epidermal sheets were
found to be largely nonreactive for the applied MC-1R
antibody in unirradiated skin. Some scattered immunor-
eactive dendritic cells, however, were detected in the basal
and suprabasal layers of the epidermal sheets (Fig 4a). To
reveal further the nature of these MC-1R-positive cells,
immunostaining with a CD1 antibody was performed (Metze
and Ru¨tten, 1999), which identified these cells as CD1-
expressing Langerhans cells. In contrast, upon irradiation
with SSR, MC-1R immunoreactivity was clearly detectable
in the majority of the epidermal cells, without any apparent
difference in the staining intensity between undifferentiated
cells in the basal layer and differentiated cells in the spinous
or granular layer (Fig 4b). Conversely, preimmune serum did
not result in any staining (not shown). As revealed by
semiquantitative analysis of the immunohistochemistry SSR
induced a significant increase of MC-1R-positive cells in the
suction blister roofs as compared with samples of uni-
rradiated skin (Table I). Furthermore, in accordance with
previous observations (Wakamatsu et al, 1997; Schiller et al,
2001) a strong PC1 and PC2 immunostaining could be
detected in epidermal keratinocytes of normal human skin
in situ. However, UV irradiation did not enhance the level of
PC1 and PC2 immunostaining of the epidermal sheets, as
compared with unirradiated skin (not shown).
Discussion
UV is one of the most crucial environmental factors with
regard to its capacity to induce skin cancer, premature
aging of the skin, and immunosuppression (reviewed in
Beissert and Granstein, 1996). Exposure to UV irradiation
has been demonstrated to modify cellular immune re-
sponses such as contact hypersensitivity and to induce
allergen-specific tolerance. The immunosuppressive effects
of UV light are mainly mediated by the short wave range
(UVB 290–320 nm), which is mostly absorbed within the
epidermis. Beside UV-induced DNA damage and keratino-
cyte apoptosis, the UV-mediated upregulation of pro-
inflammatory cytokines such as IL-1, IL-6, and TNF-a as
well as other mediators appears to be a pivotal event
responsible for the immunomodulatory activity of UV light
(reviewed in Beissert and Schwarz, 1999). On the other
hand, treatment of keratinocytes with UV is well known to
result in an increased production of immunosuppressive
cytokines such as IL-1 receptor antagonist (IL-1RA),
Figure 3
Upregulated a-MSH and IL-10 levels in suction blister fluid after UV
irradiation. Suction blisters were induced 24 h after in vivo UV
irradiation of human skin using a solar simulator or were left
unirradiated. Suction blister fluids were collected, and (a) a-MSH and
(b) IL-10 were determined using a specific radioimmunoassay or
enzyme immunoassay, respectively. Results are presented as fold
induction (mean  SD) of three individual experiments. po0.05 (control
vs UV vs sunscreen).
Figure4
UV-induced expression of MC-1R in human epidermis. Suction
blisters were induced (b) 24 h after in vivo UV irradiation using a solar
simulator or (a) were left nonirradiated, epidermal roofs were isolated,
and deparaffinized sections were stained with an antibody against
MC-1R. Bound antibodies were detected by the immunoperoxidase
technique (red staining). Significant MC-1R immunostaining was
observed in the epidermis (E) only after UV irradiation (arrows; b) but
not in nonirradiated epidermis (a). However, MC-1R immunoreactivity
was occasionally detected in scattered dendritic cells (a, large
arrowheads), which were identified as Langerhans cells by CD1
immunostaining (not shown). Scale bar¼25 mm.
Table I. SSR increases the expression of MC-1R in vivo
MC-1R positive cellsw
Volunteer Control SSR
I 0.4  0.9 14.0  6.7
II 1.2  1.8 9.6  4.1
III 0.0  0.0 4.2  1.6
Mean 0.5  0.6 9.3  4.9y
wThe expression of MC-1R was studied in human epidermis which
were left untreated, or exposed to UV irradiation using a solar simulator
(2  MED). After 24 h, epidermal roofs of suction blisters were isolated,
and deparaffinized sections were stained with an antibody against MC-
1R. At least five fields of each sample were evaluated and the number of
MC-1R postive cells (means  s.d.) calculated.
Overall mean (  s.d.) of volunteers I–III.
yPo0.05 vs control.
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transforming growth factor b, and IL-10. In animal models,
application of these cytokines has been shown to result in
UV-like immunosuppression that could be reverted by
treatment with antibodies or antagonists directed against
IL-10 (Beissert et al, 1996; Grabbe et al, 1996; Lee et al,
1997; Shreedhar et al, 1998). Thus, suppressor cytokines
released upon UV irradiation appear to function as
important mediators of UV-induced immunosuppression.
On the other hand, irradiation with short wave UVB or
UVA1 (340–400 nm) upregulates the POMC and MC-1R
mRNA expression by keratinocytes in vitro in a time-
dependent manner (Brzoska et al, 1997). Using semiquan-
titative reverse transcriptase–PCR it was demonstrated that
POMC mRNA upregulation following UVB irradiation is time
and dose dependent with a biphasic maximum induction 10
and 24 h after 10 J per m2 UVA1 or 25 mJ per cm2 UVB in
human keratinocytes (Brzoska et al, 1997). Maximum
release of a-MSH occurred 48 to 72 h after UVB irradiation
of keratinocytes in culture (Schauer et al, 1994). Like POMC
mRNA, intracellular a-MSH production and a-MSH secre-
tion is dose dependent with a maximum after 25 mJ per cm2
(Chakraborty et al, 1996). A comparable dose-dependent
regulation has been reported in human melanocytes
(Chakraborty et al, 1996) as well as mouse melanoma cells
and transformed mouse keratinocytes (Chakraborty et al,
1995).
Most interestingly, the time after UVB irradiation of
keratinocytes required for maximum POMC expression
and a-MSH release differs markedly from that needed for
the optimal generation of pro-inflammatory cytokines. In
contrast to UV-induced POMC mRNA expression, which
displays a bimodal regulation with a second peak 24 to 48 h
after UV irradiation, the expression of mRNA specific for
IL-1, IL-6, or TNF-a is typically upregulated within 1 to 2 h
after UVB exposure (Luger et al, 1999). Moreover, pro-
inflammatory cytokines such as IL-1 turned out to be potent
inducers of POMC mRNA expression and a-MSH release by
keratinocytes (Schauer et al, 1994; Chakraborty et al, 1996;
Wintzen and Gilchrest, 1996; Scholzen et al, 2000). The
presence of IL-1RA prevented upregulation of POMC
mRNA expression and a-MSH release, suggesting that
UVB indirectly via IL-1 upregulates a-MSH production
(Luger et al, 1999). On the other hand, a-MSH has been
shown to antagonize particular pro-inflammatory activities
of IL-1, such as fever, thymocyte proliferation, and
chemokine production possibly by inhibiting the binding of
IL-1b to the IL-1 receptor type 1 (Luger et al, 1999). These
findings suggest that the delayed a-MSH release after UV
irradiation could be responsible for the downregulation of
inflammatory responses, thus preventing the host from
deleterious consequences of an extended inflammatory
response. In addition, UV-induced a-MSH may contribute to
the clinically well known formation of increased epidermal
and stratum corneum thickness in chronically irradiated skin
(Pearse et al, 1987), as a-MSH significantly stimulates
keratinocyte proliferation and differentiation (Orel et al,
1997).
There is evidence, from several studies, that UV-induced
IL-10 production can have similar immunosuppressive
effects as a-MSH (Enk et al, 1995). As a-MSH can increase
in vitro the IL-10 production in human monocytes and
keratinocytes (Bhardwaj et al, 1996, 1997; Redondo et al,
1998), it may be that IL-10 induction by a-MSH mediates
some of the immunosuppressive effects of UV (reviewed in
Scholzen et al, 1999; Seiffert and Granstein, 2002). In this
study, however, due to the limited number of samples, no
entire time kinetic of IL-10 and POMC mRNA expression
was performed, and the exact time course of IL-10 and
a-MSH in vivo still awaits further elucidation. Of note,
inhibition of allergic airways inflammation in mice by
a-MSH, is mediated via IL-10 production, because IL-10
knockout mice are resistant to a-MSH treatment (Raap et al,
2003).
The in vivo relevance of the discussed findings is further
supported by studies demonstrating that irradiation of the
skin in humans results in induction of POMC expression and
a-MSH release. Accordingly, increased levels of circulating
a-MSH have been found in humans following UV irradiation
(Holzmann et al, 1983), whereas in contrast, plasma levels
of immunologically unrelated opioid peptides after sunbed
exposures remain unchanged (Gambichler et al, 2002).
Moreover, we have shown in this study that following UV
exposure to solar-simulating irradiation, suction blister fluid
obtained from UV-treated skin contained significantly
increased levels of IL-10 and a-MSH an effect, which could
be abolished by prior application of the broad-spectrum
sunscreen. These observations are in accordance with
previous studies showing that broad-spectrum sunscreens
can inhibit the UV-mediated induction of immunosuppres-
sive factors and may thereby prevent local UV-induced
immunosuppression (Hochberg and Enk, 1999; Ullrich et al,
1999). In addition, by using mRNA from blister roofs and
semiquantitative reverse transcriptase–PCR the expression
POMC and MC-1R mRNA was found to be considerably
upregulated following UV treatment. As these results are
only in part statistically significant (Fig 1) and densitometric
ratios of semiquantitative reverse transcriptase–PCR might
not always correlate with the real ratios of modulation,
further studies are required to substantiate our findings.
Albeit, one may presume that UV treatment generates
increased amounts of melanocortins as well as melanocor-
tin receptors in the skin, which may contribute to UV-
mediated effects, such as UV-induced immunosuppression,
pigmentation, and keratinocyte proliferation.
No attempt was made to measure protein production for
other POMC-derived peptides in this study. We previously
have shown, however, that normal keratinocytes in culture
synthesize and release enhanced amounts of both ACTH
and a-MSH to the culture medium after UVB irradiation
(Schauer et al, 1994). Similarly in mouse transformed
keratinocytes UVB stimulates production of MSH and
ACTH, proposing that both POMC peptides might be
involved in the response of the POMC system to UV
exposure (Chakraborty et al, 1995) and Wintzen and
Gilchrest (1996) reported that normal human keratinocytes
produce b-endorphin and b-lipotropic hormone after stimu-
lation with UV. Whether these POMC-derived peptides
exhibit physiologic relevance in human skin, remain to be
investigated. Recently, b-endorphin immunoreactivity has
been detected by immunohistochemistry in keratinocytes of
the follicular matrix and in cells of the sweat duct in human
skin in vivo, whereas no immunoreactivity was detected in
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the epidermis, nor was the staining pattern influenced by
repeated UV irradiation (Wintzen et al, 2001).
Little is known about the exact molecular mechanism
involved in the regulation of POMC and MC-1R gene
expression in human keratinocytes by UV light and IL-1.
As IL-1 is known to act by elevating intracellular cyclic
adenosine monophosphate levels (Heijnen and Kavelaars,
1991), POMC gene expression might be in part regulated
through the cyclic adenosine monophosphate mediated
pathway (Boutillier et al, 1998). Moreover, POMC mRNA
gene expression in the pituitary is known to be regulated via
protein kinase C (Loeffler et al, 1989). As 12-O-tetradeca-
noyl-phorbol-13-acetate, a well known protein kinase C
activator, also strongly upregulates POMC mRNA expres-
sion in human keratinocytes (Wintzen and Gilchrest, 1996),
POMC transcription in keratinocytes may be regulated by
multiple signaling pathways.
Whether upregulators of POMC production affect as well
the expression level of certain members of the neuropeptide
generating machinery in human skin cells, a mechanism
that would guarantee a prolonged anti-inflammatory activity
in UV-irradiated skin, has to be regarded as contentious.
Whereas in human dermal microvascular endothelial cells
PC1 mRNA seems to be regulated by UV, IL-1, and a-MSH
itself (Scholzen et al, 2000), PC1 and PC2 immunoreactivity
is constitutively expressed in the human epidermis in situ
(Wakamatsu et al, 1997; Schiller et al, 2001). In this study UV
exposure in vivo, did not lead to further enhancement of
PC1 and PC2 immunostaining. The promoter regions of
human PC2 and PC1, however, are known to contain a
cyclic adenosine monophosphate response element-like
sequence and regulation of PC1 and PC2 mRNA by
intracellular protein kinase C and protein kinase A pathways
has been demonstrated (Jansen et al, 1995; Udupi et al,
1998).
The immunomodulating effects of a-MSH are mainly
exerted via interaction with MC-1R expressing monocytes,
macrophages, or dendritic cells, whereas in addition the
anti-inflammatory function of a-MSH could be explained by
the capacity of a-MSH to downregulate the expression of
adhesion molecules on dermal microvascular endothelial
cells (Scholzen et al, 2003). Pro-inflammatory signals such
as IL-1, TNF-a, or lipopolysaccharide appear to be required
to induce MC-1R expression on inflammatory cells, epider-
mal melanocytes, keratinocytes, and endothelial cells, as
under normal conditions, without pro-inflammatory stimuli,
MC-1R is not detectable on these cells in situ by routine
immunohistochemistry. Inflammation constitutes a prere-
quisite for a-MSH in order to exert its anti-inflammatory and
immunomodulating activities. Therefore, the melanocortins
may belong to the essential pathways that have evolved to
check the persistent inflammatory reaction and to prevent
uncontrolled and chronic inflammation.
Materials and Methods
UVR source for in vivo irradiation The UVR source was SSR
from a DERMOLUM (Mu¨ller Company, Moosinning, Germany)
Solar Simulator equipped with a xenon vapor lamp OSRAM 1000
W and with a direct outlet followed by an infrared water filter. SSR
doses were routinely monitored with a broadband thermophile
radiometer (Mu¨ller Company).
Volunteers After informed consent, eight healthy volunteers were
tested during the winter months for minimal erythema dose (MED)
of SSR on the volar aspects of the forearm (1 cm  1 cm). The
volunteers were selected for the following criteria: (1) inclusion
criteria included age 18 to 45, skin types Fitzpatrick II to III, and no
history of skin cancer or photosensitivity, and (2) exclusion criteria
were pregnancy, any medication within 7 d prior to the start of the
study with the exception of oral contraception, and any investiga-
tional drug within 28 d of the start of the study. The study was
conducted according to the Declaration of Helsinki Principles and
the local institutional review board has approved the study.
Sunscreen A coded broad-spectrum sunscreen formulation
(Anthe´lios XL) and the common uncoded vehicle were provided by
La Roche-Posay, Laboratoire Pharmaceutique (Asnie`res, France).
This sunscreen, with both a high UVB (sun protection factor
(SPF)460) and UVA (immediate pigment darkening (IPD)¼ 90,
persistent pigment darkening (PPD)¼ 28) protection factors con-
tained Octocrylene (UVB), and Mexoryl XL and TiO2 (both UVA).
The products were applied at a rate of approximately 2 mg per
cm2. Sunscreens were applied 15 to 20 min before irradiation. All
applications were determined by weighing and were applied to the
demarcated area of the forearm in a visible even film.
Study design and preparation of epidermal sheets from
suction blisters Small demarcated areas (3 cm  1.5 cm) of the
volar aspects of the forearm of each individual were irradiated with
two times the MED of SSR or were left unirradiated. In three
volunteers three demarcated UV exposure areas were left either
untreated or treated with broad-spectrum sunscreen or its vehicle
control. Epidermis was obtained by the suction blister technique as
described by Kiistala and Mustakallio (1967) and Kiistala (1968)
from UV-irradiated skin and from unirradiated control sites at given
time points. Briefly, a sterile suction cup of acrylic plastic with an
exchangeable pierced acrylic plate with four 5 mm holes was
placed on the volar aspects of the forearm of each individual and a
vacuum of 250 to 300 mmHg was applied using a Dermovac
suction blister device (Ventipress Oy, Lapeenranta, Finland). Within
90 to 120 min, five separate blisters appeared, in which suction
blistering occurred at the dermoepidermal junction without any
profound alterations in the microscopic structure (Kiistala and
Mustakallio, 1967). The blister fluid was collected and stored at
801C for a-MSH and IL-10 determination. The epidermal sheets
(blister roofs) from each blister were removed using sterile forceps
and scissors, immediately placed on ice, and stored at 801C until
use. For immunohistochemistry studies duplicates of irradiated
and nonirradiated epidermal sheets from three volunteers were
fixed in 7% buffered paraformaldehyde.
Preparation of RNA Total RNA was isolated from suction blister
roofs after preparation of a suspension of epidermal cells by
limiting trypsinization using the acid guanidinium thiocyanate–
phenol–chloroform method. The RNA pellets were washed with
80% ethanol, dried, and dissolved in diethylpyrocarbonate-treated
RNAse-free water. To avoid DNA contamination the extracted RNA
was treated with 10 U RNAse-free DNase I for 1 h at 371C
(Boehringer Mannheim, Germany) in a buffer containing 1.5 mM
MgCl2, 50 mM KCl, and 10 mM Tris–HCl, pH 8.3.
Semiquantitative reverse transcriptase–polymerase chain re-
action (reverse transcriptase–PCR) For reverse transcriptase–
PCR, 1 mg of total RNA was reverse transcribed using oligo(dT)
primers and AMV Reverse Transcriptase (Promega, Madison,
Wisconsin). PCR amplification of MC-1R (416 bp), POMC (143
bp), or b-actin (838 bp, Clontech, La Jolla, California) specific PCR
products was performed with REDTaq polymerase (Sigma,
Taufkirchen, Germany) and commercially synthesized specific
primer pairs (Gibco-BRL, Gaithersburg, Maryland) as previously
reported (Hartmeyer et al, 1997; Scholzen et al, 2000). IL-10 (NCBI
accession no. U16720) was amplified using sense primer 50-
CAAGGCAAGATGGGAAACAAA-30 and the anti-sense primer 50-
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GTGGGAGGGAGGGATGAGAGG-30 resulting in an amplification
product of 470 bp. The amplification program was as follows: one
cycle of 941C/10 min, 571C/2 min, 721C/1 min followed by 33
cycles of 941C/45 s, 571C/45 s, 721C/1 min and a final cycle of
941C/45 s, 571C/45 s, and 721C/10 min. Aliquots of reaction
products were run on 1.5% agarose gels and analyzed either by
product size compared with coamplified control templates or by
cutting the isolated fragment with appropriate restriction enzymes
or by DNA sequencing.
Quantiﬁcation of PCR products To semiquantify the relative
amounts of MC-1R, POMC, or IL-10 mRNA, the band intensities of
amplified products were related densitometrically to the signal
intensity of the respective b-actin PCR product of the same
sample. Densitometrical evaluation was performed using a Biostep
Image Analysis and Photo Documentation System (transilluminator
hood/Pieper FK75121Q-IR CCD video camera connected to a PC
equipped with a frame grabber video card; Biostep GmbH,
Jahnsdorf, Germany) with Phoretix Totallab 1.00 Image Processing
and Analyzing Software (Nonlinear Dynamics, Newcastle upon
Tyne, UK). Unless stated otherwise, results from three to five
different experiments were taken and expressed as fold induction
of control as mean  SD with the density of unstimulated controls
set to 1 for each time point analyzed. Student’s t test was used to
assess the significance of the differences.
Determination of a-MSH and IL-10 For detection of
a-MSH a commercially available radioimmunoassay was used
(Euro-Diagnostica, Malmo¨, Sweden) as described (Schiller et al,
2001). IL-10 was measured using the ultrasensitive immunoassay
kit from BioSource (Camarillo, California), with a sensitivity of less
than 0.2 pg per mL and no cross-reactivity against IL-1b, IL-2, IL-3,
IL-4, IL-5, IL-6, IL-7, IL-8, IL-12, IL-13, IL-15, IL-16, granulocyte-
macrophage colony-stimulating factor, IFN-g, stem cell factor, and
TNF-a. All data are expressed as the mean  SD. The differences
between the groups were analyzed using the ANOVA test. Differ-
ences were considered statistically significant if po0.05.
Immunohistochemistry The specimens (blister roofs) were fixed
and processed as described previously (Bo¨hm et al, 1999a). For
epitope unmasking sections were microwave treated for 15 min.
Sections were subsequently quenched for endogenous peroxidase
by being incubated with 1% methanolic hydrogen peroxide for 20
min. After being rinsed with phosphate-buffered saline, unspecific
binding sites were blocked with 2% bovine serum albumin for 30
min at room temperature followed by incubation for 45 min with an
anti-MC-1R antibody at 1 mg per mL (Bo¨hm et al, 1999b). The
sections were finally developed by an indirect immunoperoxidase
technique using: phosphate-buffered saline, peroxidase-
conjugated goat-anti-rabbit antibodies (1:250, Dianova, Hamburg,
Germany), 0.01% hydrogen peroxide, and 3-amino-9-ethycarbo-
zole as a chromogenic substrate (Sigma). Negative controls
consisted of preimmune serum at the same protein concentration
as the primary antibody. Alternatively, the primary antibody was
omitted. Immunoreactivity of suction blister roofs (epidermal
sheets) for MC-1R has been evaluated by a semiquantitative
approach. Accordingly, immunoreactivity of stained tissue sections
was scored by counting MC-1R-positive cells in each specimen in
five high-power fields (  400). The average number of MC-1R-
positive cells was calculated (mean  SD), and Student’s t test
was used to test the significances of the differences.
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